GET IN TOUCH

  

e: cs@genusbreeding.co.uk   t: 0870 162 2000

Newsletter signup:

Home> News> Genus Abs To Acquire 51% Of In Vitro Brazil
GENUS ABS TO ACQUIRE 51% OF IN VITRO BRAZIL


Nantwich, Cheshire, UK (February 18th 2015)— Genus ABS, the world leader in bovine genetics, reproduction services, and artificial insemination technologies, today announces that it has signed an agreement for the acquisition of 51% of In Vitro Brasil S.A. (IVB®). IVB is a leading biotechnology company focused on the production of bovine embryos through in-vitro fertilization (IVF). IVB is based in Brazil and operates in 13 countries, including the United States, Colombia, and Uruguay.

 

This transaction strengthens Genus ABS’s global leadership in the development and delivery of differentiated bovine genetics through the introduction of IVF technology. With Genus ABS’s support and established global presence, IVB will be well-positioned to meet the growing demand for IVF in the dairy and beef industries—enabling farmers to accelerate genetic improvement in their herds.

 

“This partnership allows us to offer our customers within these 13 countries a comprehensive genetic solution with real world economic benefits,” said Saskia Korink, ABS Chief Operating Officer.

 

“The acquisition of IVB provides Genus ABS with a significant opportunity to enhance the genetic offering provided to our customers. As a global leader in its field, IVB has proven success in delivering IVF solutions to both dairy and beef customers. In the future we hope to extend this opportunity to the remaining countries in which we operate,” said David Dunlop, EMEA Marketing Director, Genus ABS.

 

IVB was established in 2002 by José Henrique F. Pontes, currently CEO of IVB, to meet the need for bovine IVF technology from commercial dairy and beef producers in Brazil. Today, IVB is the primary commercial provider of bovine IVF embryos with a leading presence in Brazil, the globe’s largest bovine IVF market, and a growing presence in other Latin American countries and the United States.

 

“This transaction combines the world’s leading bovine IVF technology company with the premier bovine genetics company,” said Jose Henrique—who will continue as CEO of IVB within Genus ABS. “We share common values in being pioneers in the industry with a strong focus on translating technical capability into value for customers.”

CONTACT OUR SALE REPRESENTATIVE

Sales Representative

Telephone number: 0870 162 2000

Email Address: cs@genusbreeding.co.uk

Please get in touch and we will get your local representative to contact you

SPEAK TO ONE OF OUR SPECIALISTS

Paul Nunn

European Business Development Manager - Products

Office: 0870 900 1270

Email address: cs@genusbreeding.co.uk

SPEAK TO ONE OF OUR SPECIALISTS

Laura Stockton

Products Co-ordinator

Office: 01270 616673

Email address: cs@genusbreeding.co.uk